• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境触发的基于锰-钆的纳米系统,通过协同放疗、消耗谷胱甘肽以及结合葡萄糖氧化酶增强活性氧爆发来抑制乳腺癌。

Tumor-microenvironment triggered Mn-Gd based nanosystem for breast carcinoma suppression via synergistic radiotherapy and glutathione-depleting along with glucose oxidase combination enhanced Ros storm.

作者信息

Su Yonghui, Guo Dongqun, Liang Yinghao, Meiheriban Tuerdimaimaiti, Chen Siyu, Tang Qian, Chen Xiqian, Huang Yan, Zhong Jianqiao, Liu Zongjunlin

机构信息

Department of Breast Surgery, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, P. R. China.

Department of Urology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, P. R. China.

出版信息

J Nanobiotechnology. 2025 Aug 11;23(1):557. doi: 10.1186/s12951-025-03636-z.

DOI:10.1186/s12951-025-03636-z
PMID:40790599
Abstract

BACKGROUND

Cancer treatment commonly involves radiation as a primary therapy, affecting nearly two-thirds of patients. The use of combination therapies is gaining traction, with the aim of achieving synergistic effects through the pharmacological interactions of multiple treatments.

METHODS AND RESULTS

In this study, we present a Mn-Gd-based bimetallic nanoplatform resembling a virus, designed with a rough surface for anchoring glucose oxidase enzymes (GOx) and coating with extracellular vehicles (EVs) on the outer layer (VMn-Gd@GOx-EVs). This platform enables a synergistic approach by combining radiation therapy (RT) with oxidative therapy. The nanoplatform offers four key benefits: targeted delivery to tumors through EVs, Mn and Gd ion release triggered by the tumor microenvironment, GOx-induced generation of HO and acidic conditions for subsequent Fenton-like reactions, and relief from hypoxia to enhance RT.

CONCLUSION

Remarkably, the VMn-Gd@GOx-EVs platform effectively induces cell death in breast carcinoma models both in vitro and in vivo by harnessing the combined effects of RT and reactive oxygen species (ROS) generated by Mn ion catalysis under X-ray irradiation. Moreover, with its magnetic resonance imaging capabilities, this multi-functional diagnostic and therapeutic platform shows significant potential for clinical tumor treatment.

摘要

背景

癌症治疗通常将放疗作为主要疗法,近三分之二的患者会接受放疗。联合疗法的应用越来越广泛,旨在通过多种治疗手段的药理相互作用实现协同效应。

方法与结果

在本研究中,我们展示了一种基于锰-钆的双金属纳米平台,其形似病毒,表面粗糙以锚定葡萄糖氧化酶(GOx),外层包覆细胞外囊泡(EVs)(VMn-Gd@GOx-EVs)。该平台通过将放射治疗(RT)与氧化疗法相结合,实现了一种协同方法。该纳米平台具有四个关键优势:通过EVs实现对肿瘤的靶向递送、肿瘤微环境触发锰和钆离子释放、GOx诱导产生羟基自由基(HO)以及酸性条件以进行后续类芬顿反应、缓解缺氧以增强放疗效果。

结论

值得注意的是,VMn-Gd@GOx-EVs平台通过利用放疗与X射线照射下锰离子催化产生的活性氧(ROS)的联合效应,在体外和体内乳腺癌模型中均有效地诱导细胞死亡。此外,凭借其磁共振成像能力,这种多功能诊断和治疗平台在临床肿瘤治疗中显示出巨大潜力。

相似文献

1
Tumor-microenvironment triggered Mn-Gd based nanosystem for breast carcinoma suppression via synergistic radiotherapy and glutathione-depleting along with glucose oxidase combination enhanced Ros storm.肿瘤微环境触发的基于锰-钆的纳米系统,通过协同放疗、消耗谷胱甘肽以及结合葡萄糖氧化酶增强活性氧爆发来抑制乳腺癌。
J Nanobiotechnology. 2025 Aug 11;23(1):557. doi: 10.1186/s12951-025-03636-z.
2
A multi-functional integrated nanoplatform based on a tumor microenvironment-responsive PtAu/MnO cascade nanoreactor with multi-enzymatic activities for multimodal synergistic tumor therapy.一种基于肿瘤微环境响应型 PtAu/MnO 级联纳米反应器的多功能集成纳米平台,具有多种酶活性,用于多模式协同肿瘤治疗。
J Colloid Interface Sci. 2025 Feb;679(Pt B):957-974. doi: 10.1016/j.jcis.2024.10.160. Epub 2024 Oct 28.
3
Cascade Enzyme Catalysis Supported Starvation and Photodynamic Synergistic Therapy for Breast Cancer.级联酶催化支持的饥饿与光动力协同治疗乳腺癌
Biol Pharm Bull. 2025;48(6):908-918. doi: 10.1248/bpb.b25-00111.
4
Nano-carriers mediate reciprocally chained promotion between ROS and mitochondrial calcium overload for enhanced antitumor therapy.纳米载体介导活性氧(ROS)与线粒体钙超载之间的相互连锁促进作用,以增强抗肿瘤治疗效果。
Acta Biomater. 2025 Jul 1;201:545-558. doi: 10.1016/j.actbio.2025.06.009. Epub 2025 Jun 16.
5
HO self-supplying cascade catalytic nanoreactors amplify oxidative stress for augmented cuproptosis-driven multimodal synergistic therapy of breast cancer.自供氢级联催化纳米反应器增强氧化应激,以促进铜死亡驱动的乳腺癌多模态协同治疗。
Colloids Surf B Biointerfaces. 2025 Oct;254:114802. doi: 10.1016/j.colsurfb.2025.114802. Epub 2025 May 16.
6
Nanocatalyst with Self-Strengthening Cascade Reaction for Enhanced Cancer Therapy.具有自增强级联反应的纳米催化剂用于增强癌症治疗
ACS Appl Mater Interfaces. 2025 Jul 9;17(27):39461-39472. doi: 10.1021/acsami.5c08291. Epub 2025 Jun 27.
7
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control.肿瘤整合素靶向葡萄糖氧化酶促进活性氧介导的细胞死亡,并与α干扰素疗法联合用于肿瘤控制。
Mol Cancer Ther. 2025 Jan 2;24(1):118-130. doi: 10.1158/1535-7163.MCT-24-0163.
8
Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese-Polydopamine Nano-Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy.多功能锰-聚多巴胺纳米免疫调节剂协同激发细胞焦亡和STING通路以增强肾细胞癌免疫治疗
Adv Healthc Mater. 2025 Jun;14(16):e2500141. doi: 10.1002/adhm.202500141. Epub 2025 May 20.
9
A versatile nanoplatform for enhanced sonodynamic therapy hypoxia alleviation, glutathione depletion, and calcium overload.一种用于增强声动力疗法、缓解缺氧、消耗谷胱甘肽和钙超载的多功能纳米平台。
J Mater Chem B. 2025 Aug 6;13(31):9559-9575. doi: 10.1039/d5tb00318k.
10
A Self-Amplifying MOF Nanoplatform for Cancer Immunotherapy Synergizing Starvation-Enhanced Cuproptosis and cGAS-STING Activation.一种用于癌症免疫治疗的自增强金属有机框架纳米平台,协同饥饿增强的铜死亡和cGAS-STING激活
ACS Appl Mater Interfaces. 2025 Jul 16;17(28):40129-40142. doi: 10.1021/acsami.5c07234. Epub 2025 Jul 1.

本文引用的文献

1
A comprehensive evaluation of stability and safety for HEK293F-derived extracellular vesicles as promising drug delivery vehicles.对HEK293F来源的细胞外囊泡作为有前景的药物递送载体的稳定性和安全性进行全面评估。
J Control Release. 2025 Jun 10;382:113673. doi: 10.1016/j.jconrel.2025.113673. Epub 2025 Mar 30.
2
Dual-pathway tumor radiosensitization strategy based on engineered bacteria capable of targeted delivery of AuNPs and specific hypoxia alleviation.基于能够靶向递送金纳米颗粒并特异性缓解缺氧的工程菌的双途径肿瘤放射增敏策略。
J Nanobiotechnology. 2025 Mar 29;23(1):254. doi: 10.1186/s12951-025-03329-7.
3
Mn(II)-MOF nanoparticles conjugated with EOB-PEG as high-performance hepatobiliary-specific MRI contrast agents.
与EOB-PEG共轭的Mn(II)金属有机框架纳米颗粒作为高性能肝胆特异性磁共振成像造影剂。
Nanoscale. 2025 Mar 7;17(10):5743-5754. doi: 10.1039/d4nr05293e.
4
Hollow mesoporous silica nanoparticles for drug formulation and delivery: Opportunities for cancer therapy.用于药物制剂和递送的中空介孔二氧化硅纳米颗粒:癌症治疗的机遇
Colloids Surf B Biointerfaces. 2025 May;249:114534. doi: 10.1016/j.colsurfb.2025.114534. Epub 2025 Jan 25.
5
Platelet membrane biomimetic nanomedicine induces dual glutathione consumption for enhancing cancer radioimmunotherapy.血小板膜仿生纳米药物诱导双重谷胱甘肽消耗以增强癌症放射免疫治疗。
J Pharm Anal. 2024 Dec;14(12):100935. doi: 10.1016/j.jpha.2024.01.003. Epub 2024 Jan 17.
6
Reprogramming Dysfunctional Dendritic Cells by a Versatile Catalytic Dual Oxide Antigen-Captured Nanosponge for Remotely Enhancing Lung Metastasis Immunotherapy.通过多功能催化双氧化物抗原捕获纳米海绵重编程功能失调的树突状细胞以远程增强肺转移免疫治疗
ACS Nano. 2025 Jan 21;19(2):2117-2135. doi: 10.1021/acsnano.4c09525. Epub 2024 Dec 31.
7
Virus nanotechnology for intratumoural immunotherapy.用于肿瘤内免疫治疗的病毒纳米技术。
Nat Rev Bioeng. 2024 Nov;2(11):916-929. doi: 10.1038/s44222-024-00231-z. Epub 2024 Sep 23.
8
A Self-Cascading Catalytic Therapy and Antigen Capture Scaffold-Mediated T Cells Augments for Postoperative Brain Immunotherapy.一种自级联催化疗法和抗原捕获支架介导的T细胞增强用于术后脑免疫治疗。
Small. 2025 Feb;21(5):e2406178. doi: 10.1002/smll.202406178. Epub 2024 Dec 15.
9
Gadolinium-Sensitive Artificial Nanochannel Membrane for Information Encryption.镧系元素敏感型人工纳米通道膜用于信息加密。
ACS Nano. 2024 Nov 19;18(46):32226-32234. doi: 10.1021/acsnano.4c12380. Epub 2024 Nov 6.
10
A Turbo-Charging System-Like Contrast Agent for MRI-Guided STING Pathway-Activated Cancer Immunotherapy.一种用于MRI引导的STING通路激活癌症免疫治疗的类似涡轮增压系统的造影剂。
Adv Sci (Weinh). 2025 Jan;12(1):e2410432. doi: 10.1002/advs.202410432. Epub 2024 Nov 3.